Management of hepatitis C in the hemophilia patient.

doi:10.1016/s0002-9343(99)00391-5

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Management of hepatitis C in the hemophilia patient.

The American journal of medicine - 27 Dec 1999

Fried M W

Abstract excerpt

Patients with hemophilia who received clotting factor concentrates before the availability of heat-treated factors in the mid-1980s were almost universally infected with hepatitis C virus (HCV). Until recently, the clinical impact of chronic hepatitis C was largely overshadowed by human immunodeficiency virus (HIV) infection in this risk group. With recent advances in treating HIV infection, there is greater...

Topics

Antiviral Agents
Biopsy, Needle
Carcinoma, Hepatocellular
Genotype
HIV Infections
Hemophilia A
Hepacivirus
Hepatitis C, Chronic
Humans
Interferon-alpha
Liver
Liver Neoplasms

Source

Open in PubMed

Identifiers

PMID: 10653465
DOI: 10.1016/s0002-9343(99)00391-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics